Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – In the rituximab era, it’s not necessary to administer prophylaxis against central nervous system (CNS) disease in patients with diffuse large B-cell lymphoma…
NEW YORK (Reuters Health) – The number of monitoring visits for patients treated for localized primary melanoma can be reduced considerably, without having much effect on spotting any…
NEW YORK (Reuters Health) – Vandetanib shows encouraging action against advanced and metastatic medullary thyroid carcinoma, researchers report in an October 24th on-line paper in the Journal of…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
NEW YORK (Reuters Health) – For the majority of women undergoing gynecologic surgery for benign conditions, intermittent pneumatic compression provides sufficient protection against venous thromboembolism (VTE). Women at…
NEW YORK (Reuters Health) – Testing for autoantibody against the 155-kDa protein is a “highly accurate” tool for diagnosing cancer-associated myositis in adults with dermatomyositis, according to a…
NEW YORK (Reuters Health) – The Oncotype DX test, based on reverse transcription polymerase chain reaction (RT-PCR), for HER2 gene amplification in breast cancers has an “unacceptable” false-negative…
NEW YORK (Reuters Health) – Laparoscopic partial nephrectomy (LPN) and laparoscopic cryoablation (LCA) are viable nephron-sparing options for patients with a small tumor in a solitary kidney, researchers…
